Intrathecal hydromorphone added to hyperbaric bupivacaine for postoperative pain relief after knee arthroscopic surgery: A prospective, randomised, controlled trial

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background and objective: Adding opioid to spinal anaesthetic provides additional analgesia during the postoperative period. The purpose of this study was to determine the dose of intrathecal hydromorphone necessary to achieve postoperative pain relief after arthroscopic knee surgery. Methods: In a prospective, double-blinded parallel, placebocontrolled manner, 60 patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anaesthesia with 0.5% hyperbaric bupivacaine 6mg combined with 0.0, 2.5, 5.0 or 10.0μg per 0.05ml hydromorphone. Fifteen patients were assigned to receive each dose. The visual analogue pain scores (VAPSs) were measured at 30 min and 2, 4, 6, 12 and 24h postoperatively, and the side-effects of hydromorphone were recorded. Results: The postoperative VAPSs at 4, 6 and 12h for the 5 and 10mg hydromorphone groups were significantly decreased, compared to the control group. The 2.5 μg hydromorphone group had lower VAPS only at 4 and 6h postoperatively. Nausea was significantly increased in the 10 μg hydromorphone group (46.6%). Conclusion: The analgesic effects of 5 and 10 μg intrathecal hydromorphone provided satisfactory pain relief for 12h postoperatively and nausea increased significantly in a dosedependent manner.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalEuropean Journal of Anaesthesiology
Volume29
Issue number1
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Hydromorphone
Bupivacaine
Arthroscopy
Postoperative Pain
Knee
Randomized Controlled Trials
Pain
Nausea
Spinal Anesthesia
Postoperative Period
Analgesia
Opioid Analgesics
Analgesics
Anesthetics
Control Groups

Keywords

  • Hydromorphone
  • Knee arthroscopy
  • Spinal anaesthesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

@article{697158c8eff84b2ea54361d10c5a0079,
title = "Intrathecal hydromorphone added to hyperbaric bupivacaine for postoperative pain relief after knee arthroscopic surgery: A prospective, randomised, controlled trial",
abstract = "Background and objective: Adding opioid to spinal anaesthetic provides additional analgesia during the postoperative period. The purpose of this study was to determine the dose of intrathecal hydromorphone necessary to achieve postoperative pain relief after arthroscopic knee surgery. Methods: In a prospective, double-blinded parallel, placebocontrolled manner, 60 patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anaesthesia with 0.5{\%} hyperbaric bupivacaine 6mg combined with 0.0, 2.5, 5.0 or 10.0μg per 0.05ml hydromorphone. Fifteen patients were assigned to receive each dose. The visual analogue pain scores (VAPSs) were measured at 30 min and 2, 4, 6, 12 and 24h postoperatively, and the side-effects of hydromorphone were recorded. Results: The postoperative VAPSs at 4, 6 and 12h for the 5 and 10mg hydromorphone groups were significantly decreased, compared to the control group. The 2.5 μg hydromorphone group had lower VAPS only at 4 and 6h postoperatively. Nausea was significantly increased in the 10 μg hydromorphone group (46.6{\%}). Conclusion: The analgesic effects of 5 and 10 μg intrathecal hydromorphone provided satisfactory pain relief for 12h postoperatively and nausea increased significantly in a dosedependent manner.",
keywords = "Hydromorphone, Knee arthroscopy, Spinal anaesthesia",
author = "Lee, {Yoon Sook} and Park, {Young Cheol} and Kim, {Jae Hwan} and Kim, {Woon Young} and Seung-Zhoo Yoon and Moon, {Man Gook} and Min, {Too Jae}",
year = "2012",
month = "1",
day = "1",
doi = "10.1097/EJA.0b013e3283476055",
language = "English",
volume = "29",
pages = "17--21",
journal = "European Journal of Anaesthesiology",
issn = "0265-0215",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Intrathecal hydromorphone added to hyperbaric bupivacaine for postoperative pain relief after knee arthroscopic surgery

T2 - A prospective, randomised, controlled trial

AU - Lee, Yoon Sook

AU - Park, Young Cheol

AU - Kim, Jae Hwan

AU - Kim, Woon Young

AU - Yoon, Seung-Zhoo

AU - Moon, Man Gook

AU - Min, Too Jae

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Background and objective: Adding opioid to spinal anaesthetic provides additional analgesia during the postoperative period. The purpose of this study was to determine the dose of intrathecal hydromorphone necessary to achieve postoperative pain relief after arthroscopic knee surgery. Methods: In a prospective, double-blinded parallel, placebocontrolled manner, 60 patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anaesthesia with 0.5% hyperbaric bupivacaine 6mg combined with 0.0, 2.5, 5.0 or 10.0μg per 0.05ml hydromorphone. Fifteen patients were assigned to receive each dose. The visual analogue pain scores (VAPSs) were measured at 30 min and 2, 4, 6, 12 and 24h postoperatively, and the side-effects of hydromorphone were recorded. Results: The postoperative VAPSs at 4, 6 and 12h for the 5 and 10mg hydromorphone groups were significantly decreased, compared to the control group. The 2.5 μg hydromorphone group had lower VAPS only at 4 and 6h postoperatively. Nausea was significantly increased in the 10 μg hydromorphone group (46.6%). Conclusion: The analgesic effects of 5 and 10 μg intrathecal hydromorphone provided satisfactory pain relief for 12h postoperatively and nausea increased significantly in a dosedependent manner.

AB - Background and objective: Adding opioid to spinal anaesthetic provides additional analgesia during the postoperative period. The purpose of this study was to determine the dose of intrathecal hydromorphone necessary to achieve postoperative pain relief after arthroscopic knee surgery. Methods: In a prospective, double-blinded parallel, placebocontrolled manner, 60 patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anaesthesia with 0.5% hyperbaric bupivacaine 6mg combined with 0.0, 2.5, 5.0 or 10.0μg per 0.05ml hydromorphone. Fifteen patients were assigned to receive each dose. The visual analogue pain scores (VAPSs) were measured at 30 min and 2, 4, 6, 12 and 24h postoperatively, and the side-effects of hydromorphone were recorded. Results: The postoperative VAPSs at 4, 6 and 12h for the 5 and 10mg hydromorphone groups were significantly decreased, compared to the control group. The 2.5 μg hydromorphone group had lower VAPS only at 4 and 6h postoperatively. Nausea was significantly increased in the 10 μg hydromorphone group (46.6%). Conclusion: The analgesic effects of 5 and 10 μg intrathecal hydromorphone provided satisfactory pain relief for 12h postoperatively and nausea increased significantly in a dosedependent manner.

KW - Hydromorphone

KW - Knee arthroscopy

KW - Spinal anaesthesia

UR - http://www.scopus.com/inward/record.url?scp=84863012670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863012670&partnerID=8YFLogxK

U2 - 10.1097/EJA.0b013e3283476055

DO - 10.1097/EJA.0b013e3283476055

M3 - Article

C2 - 21562420

AN - SCOPUS:84863012670

VL - 29

SP - 17

EP - 21

JO - European Journal of Anaesthesiology

JF - European Journal of Anaesthesiology

SN - 0265-0215

IS - 1

ER -